Has Christoph Correll received payments from drug or device companies?

Yes. Drug and device makers reported $2,261,638 in general payments to Christoph Correll across 780 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christoph Correll did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christoph Correll come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christoph Correll

Psychiatry · Glen Oaks, NYNPI 1053475954

Payments from drug & device makers

$2,261,638in general payments, 2019–2025

Across 780 payments — averaging $2899.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Takeda Pharmaceuticals U.S.A., Inc.$402K
H. Lundbeck A S$282K
Teva Pharmaceuticals USA, Inc.$246K
Takeda$225K
Alkermes, Inc.$155K
Boehringer Ingelheim$128K
plus $823K from 36 others

$8,463in research payments, 2019–2025

Across 4 payments — averaging $2115.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Teva Pharmaceuticals USA, Inc.$5K
Otsuka Pharmaceutical Development & Commercialization, Inc.$3K
Novo Nordisk AS$465

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Takeda Pharmaceuticals U.S.A., Inc.	11	$402,436
H. Lundbeck A S	115	$281,947
Teva Pharmaceuticals USA, Inc.	82	$246,096
Takeda	2	$225,334
Alkermes, Inc.	78	$155,445
Boehringer Ingelheim	72	$127,557
Mylan Inc.	37	$102,652
Janssen Research & Development, LLC	23	$80,272
Sumitomo Pharma Co., Ltd.	49	$63,559
Seqirus USA Inc	17	$63,467
AbbVie(2 entities)	38	$60,827
Sunovion Pharmaceuticals Inc.	18	$60,810
Otsuka Pharmaceutical Co., Ltd.	52	$51,052
Otsuka Pharmaceutical Development & Commercialization, Inc.	15	$50,231
E.r. Squibb & Sons, L.L.C.	32	$47,121
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	13	$38,572
Neurocrine Biosciences, Inc.	22	$32,563
Johnson & Johnson	7	$26,755
Tanabe Pharma Corporation	5	$22,400
Janssen Global Services, LLC	16	$19,317
Acadia Pharmaceuticals Inc	12	$15,494
Neurelis, Inc.	12	$13,722
Janssen Scientific Affairs, LLC	8	$12,982
Boehringer Ingelheim International GmbH	10	$10,485
Merck	10	$10,257
Lundbeck LLC	2	$4,692
Novo Nordisk AS	3	$4,583
F. Hoffmann-la Roche AG	1	$4,240
Axsome Therapeutics, Inc.	3	$3,622
Recordati_rare_diseases_inc.	2	$3,359
Bioxcel Therapeutics, Inc.	1	$3,000
LES Laboratoires Servier	1	$2,805
Biogen	1	$2,658
Sanofi US Services Inc.	1	$2,471
Hikma Pharmaceuticals USA	1	$2,000
Luye Pharma (USA) Ltd.	1	$1,800
Supernus Pharmaceuticals, Inc.	1	$1,500
Angelini Pharma Inc.	1	$1,500
Almatica Pharma LLC	2	$1,000
Boehringer Ingelheim Espana S.A.	1	$606
Vertex	1	$425
Upjohn US 1 LLC	1	$23

How this compares

$2,261,638 in reported general payments places this provider in the 95th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York →

Other psychiatry in Glen Oaks

John KaneGlen Oaks$4M
Michael KirschenbaumGlen Oaks$526K
Michael BirnbaumGlen Oaks$432K
Deepan SinghGlen Oaks$395K
Elyssa BarronWhite Plains$12.8M
Mark DibuonoStaten Island$11.9M
Ronald BrennerHempstead$11.5M
Anton PorsteinssonRochester$7.6M
Michael LiebowitzNew York$7.1M
Leslie CitromePomona$5.7M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →